[1]
“BIOACTIVE CONSTITUENTS OF SOPHORA MOLLIS AND THEIR POTENTIAL ROLE IN CLINICAL PHARMACY AND PHYSIOTHERAPY-BASED MANAGEMENT OF INFLAMMATORY CONDITIONS”, FMHR, vol. 4, no. 6, pp. 3335–3350, Jun. 2026, Accessed: Jul. 01, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/3299